John Mulcahy
Vorstandsvorsitzender bei SiteOne Therapeutics, Inc.
Aktive Positionen von John Mulcahy
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SiteOne Therapeutics, Inc.
 SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Vorstandsvorsitzender | 23.03.2021 | - |
| Gründer | 01.01.2010 | - | |
| Präsident | 23.03.2021 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 | 23.03.2021 |
Karriereverlauf von John Mulcahy
Ausbildung von John Mulcahy
| Harvard University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
Operativ
| Chief Executive Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Founder | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
SiteOne Therapeutics, Inc.
SiteOne Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology SiteOne Therapeutics, Inc. develops novel pain therapeutics and diagnostics. Its therapeutic candidates are selective inhibitors of a voltage-gated sodium ion channel. The company was founded by Sandip Biswal, Justin Du Bois, George Miljanich, John Mulcahy and David Yeomans in 2010 and is headquartered in Bozeman, MT. | Health Technology |
- Börse
- Insiders
- John Mulcahy
- Erfahrung
